secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001295947-24-000030
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Healthcare Q2 revenue $283.8M, diluted EPS $1.09; reaffirms FY2025 outlook
--------------------------------------------------------------------------------

- Revenue $283.8M (-0.9% YoY) slightly ahead of expectations; diluted EPS $1.09 vs $1.07 prior year.
- North American OTC down 1.9% to $239.8M; International OTC up 5.0% to $44.0M driven by Hydralyte.
- Free cash flow $67.8M in Q2; net cash from operations $69.8M, up 11.7% YoY.
- Repurchased ~0.2M shares for $12M in Q2; reduced debt by $75M YTD; leverage ratio 2.7x.
- Reaffirmed FY2025 outlook: revenue $1,125-1,140M, adj. diluted EPS $4.40-4.46, free cash flow $240M+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594724000030/0001295947-24-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594724000030/pbh-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001295947-24-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer